Covid-19
Conditions
Interventions
Group 1 :
Group 2:
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age: over 18 years old, gender is not limited; 2. SARS-CoV-2 nucleic acid test positive; 3. Conform to the New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Ninth Edition) new crown mild or common type; 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Acute coronary syndrome, acute heart failure, acute stroke; 2. Renal insufficiency (renal function eGFR < 30 ml/min/1.73m2); 3. Severe liver dysfunction (ALT/AST greater than 2.5 times the upper limit of normal); 4. Contraindications to the use of Naimatevir/ritonavir tablets; 5. Life expectancy is less than 24 months; 6. Unable to accept clinical follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| myocardial injury; | — |
Secondary
| Measure | Time frame |
|---|---|
| high-sensitivity troponin peak;composite endpoints (nonfatal heart failure, nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death); | — |
Countries
China
Contacts
Public ContactGu Jun
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed